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ABSTRACT ElonginsBandCaremembersofcomplexesthatincreasetheefﬁciencyoftranscriptionalelongationbyRNApoly-
meraseII(RNAPII)andenhancethemonoubiquitinationofhistoneH2B,anepigeneticmarkofactivelytranscribedgenes.Here
weshowthat,inadditiontoitsroleinfacilitatingtranscriptionofthecellulargenome,elonginBalsoenhancesgeneexpression
fromthedouble-strandedDNAgenomeofhumancytomegalovirus(HCMV),apathogenicherpesvirus.Reducingthelevelof
elonginBbysmallinterferingRNA-orshorthairpinRNA-mediatedknockdowndecreasedviralmRNAexpression,viralprotein
accumulation,viralDNAreplication,andinfectiousvirionproduction.Chromatinimmunoprecipitationanalysisindicatedviral
genomeoccupancyoftheelongatingformofRNAPII,andmonoubiquitinatedhistoneH2BwasreducedinelonginB-deﬁcient
cells.Thesedatasuggestthat,inadditiontothepreviouslydocumentedepigeneticregulationoftranscriptionalinitiation,
HCMValsosubvertscellularelonginB-mediatedepigeneticmechanismsforenhancingtranscriptionalelongationtoenhance
viralgeneexpressionandvirusreplication.
IMPORTANCE Thegeneticandepigeneticcontroloftranscriptioninitiationatbothcellularandviralpromotersiswelldocu-
mented.Recently,theepigeneticmodiﬁcationofhistoneH2Bmonoubiquitinationthroughoutthebodiesofcellulargeneshas
beenshowntoenhancetheelongationofRNApolymeraseII-initiatedtranscripts.Mechanismsthatmightcontroltheelonga-
tionofviraltranscriptsarelesswellstudied.Hereweshowthat,aswithcellulargenes,elonginB-mediatedmonoubiquitination
ofhistoneH2Balsofacilitatesthetranscriptionalelongationofhumancytomegalovirusgenes.Thisandperhapsotherepige-
netic markings of actively transcribed regions may help in identifying viral genes expressed during in vitro latency or during
naturalinfectionsofhumans.Furthermore,thisworkidentiﬁesanovel,tractablemodelsystemtofurtherstudytheregulation
oftranscriptionalelongationinlivingcells.
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T
heelonginBCcomplexisaheterodimercomposedofthe118-
amino-acid (18-kDa) elongin B and 112-amino-acid (15-
kDa)elonginCproteins(1).Thesetwoproteins,whicharefound
almost exclusively in this binary complex, were identiﬁed as pos-
itive regulators of elongin A, an RNA polymerase II (RNAPII)
elongationfactor(1).ThetrimericelonginABCcomplex(termed
SIII) stimulates the rate of elongation by RNAPII in vitro by de-
creasing transient pauses, likely through promoting proper align-
mentofthe3=endofthenascentRNAwiththeenzymeactivesite,
thus preventing polymerase backtracking and stalling (2).
TheelonginBCcomplexalsofacilitatestheclearanceofpersis-
tently stalled polymerases that result, for example, during tran-
scriptional elongation on damaged templates (3, 4). Phosphory-
lation of serine 5 in the C-terminal domain (CTD) of Rpb1, the
largest subunit of RNAPII, and monoubiquitination by the yeast
Rsp5 ubiquitin ligase (human homologue NEDD4) appear to be
required for elongin ABC-mediated polyubiquitination of ar-
rested polymerases (3, 4). The subsequent proteasomal degrada-
tion of the stalled and polyubiquitinated RNAPII clears the tem-
plate, enabling subsequent transcription (3, 4).
Furthermore, elongin C participates in a ubiquitin ligase com-
plex with the SWI/SNF-A component BAF250b to mediate the
monoubiquitinationofhistoneH2Batlysine120(5).Monoubiq-
uitinated H2B (UbH2B) is found associated with the transcribed
regionsofhighlyexpressedhumangenes(6–9).Thismodiﬁcation
is dynamic in nature and thought to facilitate the passage of RNA
polymerases through the nucleosomes they encounter during the
process of transcriptional elongation (10–12). The prevailing
model posits that UbH2B increases the association of histone
chaperones with actively transcribed chromatin, allowing more
efﬁcientdisassemblyofnucleosomesinfrontofRNAPII,aswellas
their efﬁcient reassembly behind the transcribing enzyme. Thus,
elongin proteins facilitate transcriptional elongation by multiple
mechanisms.
In addition to enhancing transcription elongation, elongins B
andCarefoundincomplexeswithacullinfamilyprotein(Cul2or
Cul5), the ring ﬁnger protein Rbx1, and a substrate-targeting
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their eventual proteasomal degradation. Such substrates include
p53(13),HIF-1(14),Rb(15),andAPOBEC3G(16).Becausethe
elonginBCproteinsassociatewithsequence-speciﬁcmotifsfound
within the substrate-binding proteins, these factors are often
calledBC-boxproteins(17–20).Multiplecellular(e.g.,elonginA,
BAF250b, and the von Hippel-Lindau tumor suppressor) and vi-
ral (e.g., human immunodeﬁciency virus Vif, adenovirus E4orf6,
and human papillomavirus E7) BC-box proteins, as well as their
substrates, have been identiﬁed (3, 5, 13–16, 20, 21).
ThemajorityofDNAviruses,includinghumancytomegalovi-
rus (HCMV), depend on cellular transcriptional machinery to
transcribefunctionalviralmRNAs(22).Therefore,virusessuchas
HCMV provide tractable models to understand transcriptional
regulation. HCMV is the prototypic member of the Betaherpesvi-
rus family (22). It is a ubiquitous human pathogen that causes
severe morbidity and mortality, especially in people with an im-
mature or compromised immune system. HCMV is the leading
viral cause of birth defects (23, 24) and is associated with age-
related immunosenescence and proliferative diseases, including
atherosclerosis, restenosis, and certain cancers (25–29).
HCMV gene expression is temporally regulated (22) and initi-
ates with the immediate-early (IE) genes from the major IE pro-
moter(MIEP).TheactivityoftheMIEPiscontrolledinpartbyan
intrinsic cellular antiviral defense that silences the promoter, me-
diatedinpartbythecellulartranscriptionalcorepressorDaxx(30,
31). Upon productive, lytic HCMV infection, this defense is neu-
tralized by the viral pp71 protein. A component of the tegument
layer of infectious virions (32), pp71, is delivered directly to cells
upon viral entry and migrates to the nucleus, where it induces the
proteasomaldegradationofDaxxtofacilitateviralIEgeneexpres-
sion (30). These newly expressed viral IE proteins trigger the sub-
sequent events of the productive infectious cycle, such as early
gene expression, viral DNA replication, late gene expression, and
the release of infectious progeny virions (22).
Withadesiretoaddresshowadditionalcellularproteinsmight
regulate HCMV gene expression, we investigated a potential role
for the elongin BC complex during HCMV infection. We found
that depletion of elongin B reduced viral mRNA levels, viral pro-
tein expression, and viral DNA replication, resulting in reduced
progenyvirusproduction.Negativeeffectsonviralprotein,DNA,
and progeny virion levels are likely secondary to the decreases in
viral mRNA levels that we observed. Elongin B depletion did not
restricttheabilityofpp71tomediatethedegradationofDaxxbut
diddecreasetheviralgenomeassociationofUbH2Bandtheelon-
gatingformofRNAPII.OurdataindicatethatelonginBfunction
is required for efﬁcient HCMV transcript accumulation and pro-
ductivereplicationandimplicateefﬁcienttranscriptelongationas
a signiﬁcant determinant of successful HCMV infection.
RESULTS
Elongin B is required for efﬁcient HCMV replication. To deter-
mine if elongin B or elongin C is required for HCMV replication,
we generated, by retroviral transduction and drug selection, cells
that should constitutively express short hairpin RNAs (shRNAs)
designed to knock down the levels of either protein. While the
levels of elongin B or the control protein Skp1, an elongin C ho-
molog, were substantially reduced in the relevant drug-selected
cell populations (~90% reduction), those of elongin C were not
(Fig. 1A). That elongin C levels are reduced in shEloB cells is not
surprising because elongin B is known to stabilize elongin C by
forming a heterodimer (1). Because of our inability to generate
stable elongin C knockdown cells, we focused our subsequent ex-
perimentation on elongin B.
HCMV appeared to enter parental telomerase-immortalized
human foreskin ﬁbroblasts (Tert-HFs; control) and shEloB and
shSkp1 cells with equal efﬁciency, as evidenced by the equivalent
levels of tegument-delivered pp71 found in cell lysates at 4 h
postinfection(hpi)(Fig.1B).Newlyexpressedviralproteinsofthe
immediate-early (IE1), early (UL44 and pp71), and late (pp28)
temporal classes accumulated to roughly equivalent levels in con-
trol and shSkp1 cells but to reduced levels in shEloB cells. Off-
target effects of the speciﬁc targeting sequence are unlikely to be
responsible for the decreased viral gene expression observed in
cells constitutively expressing the shRNA to elongin B because
transient transfection of Tert-HF cells with either of two small
interfering RNAs (siRNAs), but not a scrambled siRNA, also re-
sulted in decreased viral gene expression upon HCMV infection
(Fig. 1C).
Other assays used to measure efﬁcient lytic replication also
indicated that viral replication was reduced in shEloB cells. Viral
DNA synthesis at 72 hpi was decreased over 5-fold in shEloB cells
compared to that in control cells, even though viral DNA levels at
6 hpi, a measure of viral entry, were equivalent (Fig. 1D). Simi-
larly, both growth curve (Fig. 1E) and endpoint (Fig. 1F) analyses
showed that infectious progeny virion release from shEloB cells
was approximately 100-fold lower than that from control or
shSkp1 cells. Taken together, these results demonstrate that
elongin B is required for efﬁcient HCMV replication.
Elongin B is not required for pp71-mediated Daxx degrada-
tion but is required for viral transcript accumulation during
HCMV infection. Elongin B negatively regulates the stability of
p53, HIF-1, Rb, APOBEC3G (20, 21), and likely other proteins
andpositivelyregulatestheprocessoftranscriptionbyfacilitating
transcript elongation as described above (1, 3, 4). We wanted to
determine whether effects on protein degradation and/or tran-
scription correlate with the decreased replication of HCMV in
cells with reduced elongin B.
Both elongin B (20, 21) and pp71 (30, 33, 34) participate in
reactions that lead to the proteasomal degradation of targeted
substrates. One pp71 substrate, Daxx, represses viral IE gene ex-
pression prior to its proteasomal degradation induced by pp71
(31, 35). Viruses that lack pp71 (36) or express a mutant protein
unable to bind (37, 38) or degrade (30, 39) Daxx show reduced
viralgeneexpressionandgrowtolowertiters,similartowild-type
virus in shEloB cells (Fig. 1). To determine if the growth defect in
shEloB cells could possibly result from an inability of pp71 to
degradeDaxx,weaskedifelonginBisrequiredforpp71-mediated
Daxx degradation. Neither the transient knockdown of either
elongin B or elongin C (Fig. 2A) nor the constitutive knockdown
of elongin B (Fig. 2B) impaired the ability of tegument-delivered
pp71 to induce Daxx degradation upon HCMV infection. These
experiments suggest that neither elongin B nor elongin C is re-
quired for pp71-mediated Daxx degradation and that elongin B
participates in a different step required for efﬁcient HCMV repli-
cation.
WenextcomparedHCMVmRNAlevelsincontrolandshEloB
cells to determine if decreased levels of elongin B affect viral tran-
script levels. We found that messages encoding the major
immediate-early proteins (Fig. 2C) and overlapping messages
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mulatedinshEloBcellstolevelsapproximately10-foldlowerthan
thoseincontrolcells.Therefore,elonginBisrequiredforefﬁcient
HCMV transcript accumulation. Furthermore, it is likely that the
observed defects in viral protein accumulation, viral DNA repli-
cation, and infectious virion release in shEloB cells are secondary
effects resulting from defects in viral transcription.
Less monoubiquitinated histone H2B and elongating RNA
polymerases are found associated with an HCMV gene in cells
withreducedlevelsofelonginB.TheelonginBCcomplexmedi-
ates the polyubiquitination of RNAPII, leading to its proteasomal
degradation (3, 4), as well as the monoubiquitination of histone
H2B,withoutaffectingitsstability(5).Eitheroftheseactivitieshas
the potential to modulate transcriptional elongation. To deter-
mine if altering levels of RNAPII or UbH2B correlate with de-
creased HCMV transcript accumulation in shEloB cells infected
with HCMV, we analyzed the steady-state levels of these proteins
in infected cell lysates. We used two different antibodies to mon-
itor RNAPII, one (H14) that detects the serine 5-phosphorylated
CTD initiating form and one (H5) that detects the serine
2-phosphorylated CTD elongating form (41, 42). In experiments
where HCMV protein accumulation was clearly lower in shEloB
cells than in control cells, no signiﬁcant difference in either form
ofRNAPIIwasdetected(Fig.3A).Thus,globaleffectsonRNAPII
stability do not correlate with the reduced viral gene expression
observed upon HCMV infection of shEloB cells.
We next examined the steady-state levels of total histone H2B
and monoubiquitinated histone H2B. The overall level of histone
H2B did not vary substantially in any of the samples analyzed
(Fig. 3B). However, in uninfected cells, the levels of UbH2B were
substantially lower in shEloB cells than in control or shSkp1 cells
(Fig. 3B). Interestingly, HCMV infection appeared to induce an
increase in the level of UbH2B at 4 hpi, most notably in shEloB
cells. As H2B ubiquitin ligases associate with the complexes that
activate transcription (7, 8) and as HCMV induces a burst of cel-
lular gene expression early after infection (43), this is perhaps not
surprising. This increase in UbH2B, especially in shEloB cells, is
likely mediated by RNF20 or another H2B ubiquitin ligase (44–
46). Importantly, lower levels of UbH2B clearly correlated with
reduced HCMV gene expression in cells with reduced levels of
elongin B.
UbH2B is an epigenetic mark for sites of active transcription
(7–9, 11). Therefore, we determined, with a chromatin immuno-
precipitation (ChIP) assay, whether or not the levels of DNA-
associated UbH2B (normalized to total H2B occupancy) varied
between the viral and cellular genomes in the presence of normal
or reduced levels of elongin B. For the cellular genome, we ana-
lyzed UbH2B association with a single locus in the body of the
actin gene. For the HCMV genome, we analyzed four loci within
the UL47 and UL48 genes (Fig. 4A), the two longest open reading
frames (ORFs) present in the virus, at 2,944 and 6,722 bp, respec-
tively (47). As most HCMV genes are unspliced, rather short, and
FIG 1 Elongin B is required for efﬁcient HCMV replication. (A) Western blot analysis of whole-cell lysates from Tert-HFs (control) or derivatives selectedt o
express shRNAs to elongin B (EloB), elongin C (EloC), or Skp1. In all Western blot assays, tubulin (Tub) served as a loading control. Band intensities were
quantiﬁed using the Scion image program, normalized relative to the quantity of their respective tubulin bands, and expressed as percentages of the strongest
value. (B) Lysates from cells infected with HCMV were harvested at the indicated times (hours) postinfection and analyzed by Western blot assay with the
indicated antibodies. (C) Lysates from HFs transfected with distinct siRNAs directed at EloB (no. 1 or 2) or with a scrambled siRNA for 48 h and then infected
withHCMVwereharvestedattheindicatedtimesandanalyzedbyWesternblotassay.(D)ViralDNAaccumulationwasmeasuredbyqPCRwithaprimer-probe
set corresponding to the major IE gene using total DNA isolated from HCMV-infected control or shEloB cells at the indicated times postinfection. Values were
normalizedtocellular-actinlevelsandareexpressedasn-foldchangesversusIElevelsmeasuredincontrolcellsat6hpi.Errorbarsrepresentthestandarderror
of the mean. (E) Viral growth curves after infection with HCMV in control or shEloB cells were determined by plaque assay of culture supernatants. Error bars
represent the standard error of the mean. (F) Viral titers achieved at 7 days in supernatants from HCMV-infected cells were determined by plaque assay. Data
from triplicate experiments with standard errors are shown.
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protocol, distinguishing proteins associated with promoter re-
gions from those associated with the bodies of HCMV genes is
challenging.However,utilizingtheselongORFsprovidesthebest
opportunity to distinguish between these different gene positions
with this assay. Note that splicing does not appear to signiﬁcantly
altertherateoftranscriptionalelongation,atleastatthelocitested
(48).
Transcriptioninitiatesjustupstreamoftheinitiatingcodonsof
both UL47 and UL48 and terminates subsequent to a polyadenyl-
ation site just beyond the terminating codon of UL48 (47). Thus,
the transcript encoding UL47 also passes through the UL48 gene.
Primersweredesignedtoanalyzethe5=regionofUL47(L0)orthe
5= (L1), central (L2), and 3= (L3) regions of UL48 (Fig. 4A). We
observed UbH2B association with both the cellular and viral ge-
nomes in both control and shEloB cells (Fig. 4B). The levels of
UbH2B found on the cellular actin gene were, on average, 30%
lower in shEloB cells than in control cells, although the observed
difference was not statistically signiﬁcant. In contrast, the average
levels of UbH2B associated with different regions of the HCMV
genome were substantially lower (L0, 47%; L1, 51%; L2, 69%; L3,
64%) in shEloB cells than in control cells (Fig. 4B). Importantly,
these observed differences between the two cell populations were
statistically signiﬁcant. These data indicate that lower UbH2B oc-
cupancy on the viral genome correlates with decreased viral gene
expression during HCMV infection of cells with decreased levels
of elongin B.
Finally,wesoughttouncoverapotentialmechanismbywhich
elonginBandUbH2BmightenhanceHCMVgeneexpression.As
elonginBhaslongbeenassociatedwithtranscriptionalelongation
(1), we focused on this aspect of gene expression. Elongation efﬁ-
ciency in vivo can be measured by examining the occupancy of
differently modiﬁed forms of RNAPII at different loci in an ac-
tively transcribed gene (2, 49). Therefore, we used a ChIP assay to
analyzenonphosphorylated,initiating(serine5-phosphorylated),
orelongating(serine2-phosphorylated)RNAPIIatthe5=,central,
and 3= regions of the viral UL47 and UL48 genes (Fig. 4C). Note
that RNAPII occupying the genomic region surveyed by primer
pairL1willrepresentelongatingpolymerasesthatstartedatUL47
and initiating polymerases that started at UL48 (Fig. 4A).
The 8WG16 antibody recognizes the nonphosphorylated
form, as well as the serine 5-phosphorylated (initiating) form, of
RNAPII. ChIP analysis using 8WG16 or H14 (initiating) detected
indistinguishable levels of RNAPII at all locations throughout
UL47 and UL48 in control and shEloB cells (Fig. 4C). However,
UL47 and UL48 occupancy by the serine 2-phosphorylated elon-
gatingformofRNAPIIwassigniﬁcantlylowerinshEloBcellsthan
incontrolcells(Fig.4C).Themagnitudeofthedifferencebetween
FIG 2 Elongin B is not required for pp71-mediated degradation of Daxx but
isrequiredforviraltranscriptaccumulationduringHCMVinfection.(A)HFs
were transfected with scrambled siRNA (columns scr) or siRNAs directed at
elonginB(columnsB),elonginC(columnsC),orelonginsBandC(columns
BC)for48h.CellsweretheninfectedwithHCMV.Lysateswereharvestedat
the indicated times postinfection and analyzed by Western blot assay with the
indicated antibodies. (B) Lysates from HCMV-infected cell populations were
harvested at the indicated times postinfection and analyzed by Western blot
assay. (C and D) Control or shEloB cells were infected with HCMV, and total
RNA was harvested at the indicated times. Expression of major IE or pp65/
pp71 RNA (C and D, respectively) was determined by reverse transcription-
qPCR. Samples were normalized to cellular -actin RNA levels, and data are
expressedasn-foldchangescomparedtotheIElevelmeasuredincontrolcells
at 6 hpi (C) or pp65/pp71 levels measured in control cells at 24 hpi (D). Mean
values from three independent experiments are shown. Tub, tubulin.
FIG 3 Elongin B does not change global RNAPII stability but does affect the
overall levels of histone H2B monoubiquitination. (A and B) Lysates from
HCMV-infectedcellpopulationswereharvestedattheindicatedtimespostin-
fectionandanalyzedbyWesternblotassaywiththeindicatedantibodies.Actin
served as a loading control in panel B. Band intensities were quantiﬁed using
the Scion image program, normalized relative to the quantity of their respec-
tivetubulin(Tub)oractinbands,andexpressedaspercentagesofthestrongest
value.
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the 3= end of UL48. These data indicate that elongin B affects the
occupancy of the elongating form of RNAPII on the viral UL47
and UL48 genes and imply that elongin B may facilitate efﬁcient
HCMV infection by promoting the elongation phase during the
transcription of viral genes (Fig. 5).
DISCUSSION
Histone modiﬁcations that modulate transcript initiation affect
bothcellularandviralgeneexpression.ForHCMV,histoneH4,as
well as H3K9 and H3K14 acetylation and H3K9 dimethylation
correlatewithtranscriptionallyactiveorsilentviralgenes,respec-
FIG 4 Less monoubiquitinated histone H2B and elongating RNAPIIs are associated with an HCMV gene in elongin B-depleted cells. (A) Schematic represen-
tation of the HCMV UL46 to UL48 genes. The dotted line, stripes, and the shading represent UL46, UL47, and UL48, respectively. Primer-probe pairs for the
ChIP-qPCR analysis are indicated (L0 to L3 [L, locator]). (B and C) Control or shEloB cells were infected with HCMV at an MOI of 0.3. After 60 h, cells were
subjected to ChIP with the indicated antibodies. Precipitated DNA was subjected to qPCR analysis with the primer-probe pairs described in panel A. All ChIP
data represent the mean and standard error of the mean from three independent experiments. An asterisk indicates a statistically signiﬁcant difference. (B) For
each primer-probe pair, ChIP values were normalized to the corresponding total H2B ChIP and are represented as the ratio of UbH2B to H2B compared to the
value obtained with the L0 primer-probe pair observed in control cells. (C) Each ChIP value is represented as a percentage of the respective input DNA.
FIG 5 Proposed model of the mechanism of action of UbH2B in cellular and viral gene transcriptional elongation. (A) Ubiquitin ligase elongin BC complex
induces monoubiquitination of histone H2B on genes, which enhances the elongation rate of RNAPII to efﬁciently transcribe genes. (B) Elongin B depletion
resultsininefﬁcientmonoubiquitinationofhistoneH2Battheviralgenomebutnotthecellularactingene.DecreasedlevelsofmonoubiquitinatedhistoneH2B
results in less elongating RNAPII, which leads to decreased accumulation of viral transcripts.
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in part by elongin B, to the list of epigenetic mechanisms that
control HCMV gene expression and propose that efﬁcient elon-
gationisanadditionalstepinthetranscriptioncyclethatiscritical
for productive HCMV infection.
In cells where the levels of elongin B have been reduced
through RNA interference, the accumulation of viral mRNAs,
proteins, DNA, and infectious progeny is reduced during HCMV
infections (Fig. 1). The event most likely to be directly effected by
elongin B deﬁciency is the transcriptional elongation of viral
genes. We found reduced levels of HCMV genome-associated
monoubiquitinatedhistoneH2B,aknownsubstrateofanelongin
B-containing ubiquitin ligase (5), in cells with reduced levels of
elongin B (Fig. 4B). Furthermore, we also detected reduced levels
ofelongatingformsofRNAPIIassociatedwiththeviralgenomein
these cells (Fig. 4C). From this, we conclude that the decrease in a
speciﬁc epigenetic modiﬁcation (UbH2B) of viral chromatin in
the absence of sufﬁcient elongin B correlates with, and perhaps
causes,decreasedHCMVtranscription,leadinginturntoreduced
HCMV replication (Fig. 5).
Interestingly,substantialamountsofserine5-phosphoarylated
(initiating) polymerases were found throughout the body of the
UL48 gene (Fig. 4C). Transcripts antisense to UL48 have been
detected in HCMV-infected cells (52), and thus, promoter ele-
ments (where serine 5-phosphorylated RNAPII would be found)
may be present within the UL48 gene on the opposite strand.
Alternatively, this observation may be linked to splicing. The
RNAPIICTDactsasascaffoldtoassembleprocessingfactors(48).
Most HCMV genes (including UL48) produce mRNAs that are
unspliced (53). Thus, the timing of serine 5 dephosphorylation
may be subtly different between RNAPIIs transcribing (un-
spliced)viralgenesandthosetranscribing(spliced)cellulargenes.
Eventhoughtranscriptionalelongationappearstobeimpaired
in the absence of elongin B, stalled polymerases did not accumu-
late to high levels on the viral UL47 or UL48 gene (Fig. 4C). This
agrees with our (Fig. 3A) and previous (42) observations that
RNAPII levels are not reduced during HCMV infection. Irrevers-
iblystalledpolymerasesarepolyubiquitinatedanddegraded(54),
for example, in herpes simplex virus type 1-infected cells (55, 56).
This seems to imply that the elongation defect imposed by de-
creased levels of UbH2B, while signiﬁcant, is not as severe as that
imposed by other lesions, such as DNA damage. Alternatively,
HCMV may have an as-yet-undescribed degradation-
independent mechanism to clear stalled polymerases.
The overall level of UbH2B was increased upon HCMV infec-
tion,eveninelonginBknockdowncells.AsHCMVisknown(22)
tostimulatehostcellgeneexpression(aswellastoexpressnumer-
ous viral genes), and as multiple H2B ubiquitin ligases may exist
(7), this is perhaps not surprising. Mechanistically unexplained is
themoresubstantialdecreaseinUbH2Bassociationwiththeviral
UL47 and UL48 genes compared to the cellular actin gene
(Fig. 4B). It remains to be determined how this might occur,
whether it extends to additional viral and cellular genes, and
whether or not similar results would be obtained in cells depleted
in other potential H2B ubiquitin ligases.
Degradation of the transcriptional corepressor Daxx by the
viraltegumentproteinpp71stimulatesviralgeneexpression(30).
Although elongin B is known to serve as an adaptor for viral
protein-assisted polyubiquitination and subsequent proteasomal
degradation of cellular substrates (21), we found no indication
that elongin B plays a substantial role in the pp71-mediated deg-
radation of Daxx. This may not be surprising, as the undeﬁned
pathway through which pp71 targets its substrates for protea-
somal degradation has been characterized as ubiquitin indepen-
dent (33, 34).
ElonginBformsacomplexwithelonginC.Whilewewereable
totransientlyknockdownthelevelsofelonginCwithasiRNA,we
were unable to select for constitutive elongin C knockdown cells
withashRNAwiththeidenticalsequence.Itispossiblethatlowor
absent elongin C protein levels are incompatible with human cell
survival, as depletion of the ELC gene in Caenorhabditis elegans
causes severe defects in chromosomal dynamics and cell prolifer-
ation(57).Thus,whilewesuspectthatelonginCisrequiredalong
with elongin B for efﬁcient HCMV replication, we have not di-
rectly tested this hypothesis.
The epigenetic regulation of transcript initiation at promoters
is well appreciated, but the observations that elongation also rep-
resentsasigniﬁcantcontrolpointduringtranscriptionthatcanbe
enhanced by the epigenetic modiﬁcation of histone proteins (2,
49,58)arenotaswellknown.Thedatapresentedheresuggestthat
the importance of the regulation of transcriptional elongation in
cellular gene expression also extends to viral templates. The sub-
stantial effects of transcriptional elongation on HCMV gene ex-
pression reported here are somewhat surprising. The typical hu-
mangeneis30timeslongerthantheaverageHCMVgene(53,59).
Furthermore, the human genome displays, in general, a higher
level of chromatinization than the HCMV genome (60). Thus,
nucleosometraversalbyelongatingRNAPIIovertheentirelength
of a gene might be expected to represent a more signiﬁcant im-
pediment to cellular than to viral transcription. However, our
results clearly show that elongin B, a protein historically impli-
cated in transcriptional elongation, facilitates HCMV gene ex-
pression and productive infection. The viral capture of cellular
transcriptional elongation mechanisms that we report here pro-
vides additional models with which to study them, as well as a
potential therapeutic target for antivirals.
MATERIALS AND METHODS
Cells, viruses, antibodies, and Western blot assays. HFs or Tert-HFs
were maintained and infected with HCMV strain AD169 as previously
described(61).Inallexperiments,cellswereinfectedwithstrainAD169at
a multiplicity of infection (MOI) of 0.1, unless described otherwise. Viral
titersinsupernatantsfromgrowthassaysweredeterminedintriplicateby
plaque assay. Antibodies to the following proteins were from commercial
sources: Daxx (D7810; Sigma), tubulin (DM 1 A; Sigma), elongin B (sc-
11447; Santa Cruz), elongin C (613102; Bio Legend), Skp1 (610530; BD
Biosciences),UL44(CA006;Virusys),histoneH2B(17-10054;Millipore),
UbH2B (17-650; Millipore), RNAPII 8WG16 (MMS-126R; Covance),
H14(MMS-134R;Covance),andH5(MMS-129R;Covance).Antibodies
against pp28 (CMV157), pp71 (2H10-9), and IE1 (1B12) have been pre-
viously described (30, 62). Secondary antibodies were from Chemicon.
Cells were lysed in either 1% sodium dodecyl sulfate (SDS) lysis buffer
(20 mM Tris [pH 8.0], 250 mM NaCl, 3 mM EDTA, 10% glycerol, 1%
SDS, 0.5% NP-40, protease inhibitors) for H2B detection or radioimmu-
noprecipitation assay buffer as described previously (33). Equal amounts
ofproteinwereseparatedbySDS-polyacrylamidegelelectrophoresis,im-
mobilized on Optitran membranes, and probed with the indicated anti-
bodies as previously described (61).
qPCR analysis. Total RNA and DNA isolation and quantitative real-
time PCR (qPCR) were performed as previously described (62). The oli-
gonucleotides used for qPCR are listed in Table 1. qPCR was performed
on an ABI 7900HT, and data were analyzed using the SDS 2.2.1 program.
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formed in triplicate from at least three independent experiments.
ChIP-qPCR analysis. ChIP analysis with anti-H2B or anti-UbH2B
wasperformedusing107cellsinfectedwithHCMV(MOI0.3)for60h.
Cells were ﬁxed with 1% formaldehyde and lysed, and aliquots were
stored as input controls. ChIP assays were performed as previously de-
scribed (63), and immunoprecipitated DNA was analyzed by qPCR as
described above. All ChIP-qPCRs were performed in triplicate from at
least three independent experiments.
RNA interference. Synthetic siRNAs were purchased from Dharma-
con.ThesequencesarelistedinTable1.HFsorTert-HFsweretransfected
with siRNA (1 to 2 g) by using the Nucleofector kit (VPI-1002; Amaxa
Biosystems) and following the manufacturer’s protocol. Transfected cells
were cultured for 48 h and then infected with HCMV. Knockdown of
endogenous elongin B, elongin C, or Skp1 was achieved using shRNAs
stablyexpressedinTert-HFsaspreviouslydescribed(39).Sequence1was
used for the constitutive knockdown of elongin B.
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